144 Participants Needed

Walking Exercise for Mild Cognitive Impairment

(EXEC Trial)

Recruiting at 1 trial location
UG
Overseen ByUlf G Bronas, PhD
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have a major psychiatric disorder or unstable clinical depression, medication adjustments within 3 months of enrollment may affect eligibility.

What data supports the effectiveness of the treatment Walking Exercise for Mild Cognitive Impairment?

Research shows that exercise can significantly improve cognitive function in people with mild cognitive impairment. Studies have found that various forms of exercise, including walking, can enhance cognitive abilities and physical function, making it a promising treatment option.12345

Is walking exercise safe for people with mild cognitive impairment?

Research shows that home-based exercise programs, including walking, are generally safe for people with mild cognitive impairment. Studies found no major adverse events, and participants were able to complete the exercises successfully.46789

How is home-based walking exercise different from other treatments for mild cognitive impairment?

Home-based walking exercise is unique because it is a low-cost, low-technology treatment that can be done at home, making it accessible and easy to incorporate into daily life. Unlike other treatments that may require special equipment or settings, walking is simple and has been shown to improve cognition and mobility in older adults.48101112

Research Team

UG

Ulf Bronas, PhD

Principal Investigator

Columbia University

Eligibility Criteria

This trial is for English-speaking adults aged 55 or older with stage 3-4 chronic kidney disease and mild cognitive impairment, but no major head trauma, dementia, severe physical limitations, uncontrolled heart conditions, high blood pressure, or psychiatric disorders requiring medical therapy. Participants must be able to undergo an MRI and not be in a supervised exercise program.

Inclusion Criteria

You have mild problems with memory and thinking, scoring between 18 and 26 on a memory and thinking test called the MOCA.
You are able to have a magnetic resonance imaging (MRI) scan.
My kidney function is moderately to severely reduced.
See 3 more

Exclusion Criteria

You have an unexpected illness or disability that would make it difficult for you to do memory tests or exercise.
You have a condition or device that makes it unsafe for you to have an MRI scan, such as a pacemaker, metal fragments in your body, or a history of claustrophobia.
I was diagnosed with depression or had a change in my depression medication in the last 3 months.
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Baseline Assessment

Participants undergo tests for heart health, physical function, memory testing, and brain structure and function using imaging

1-2 weeks
1 visit (in-person)

Treatment

Participants are randomized to a 6-month home-based walking program or health education, with ongoing telephone coaching and use of a Fitbit fitness tracker

6 months
1 visit per week (in-person) in month 1, bi-weekly calls from month 2-6

Follow-up

Participants are monitored for changes in cognitive function, brain structure, and other health metrics

4 weeks
1 visit (in-person)

Treatment Details

Interventions

  • Attention control
  • Home-based walking exercise
Trial OverviewThe study is testing if a 6-month home-based walking exercise can improve memory and brain health compared to receiving health education. It targets older adults with chronic kidney disease who also have mild cognitive issues.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Home-based walking exerciseExperimental Treatment1 Intervention
A 6-month partially supervised walking exercise training using a tapered approach. Participants begin with exercising (walking) in person, on-site one time per week and 3 times per week at home for a minimum exercise dosage of 30 minutes of accumulated exercise per session during month 1. During month 2, participants will exercise on-site once every other week and 3-4 times per week at home a minimum exercise dosage of 30 minutes of accumulated exercise per session. During months 2-6, participants will exercise at home 4 times per week for a minimum exercise dosage of 30 minutes of accumulated exercise per session and they will receive a phone call every two weeks to help coach and address any problems. Participants will receive a Fitbit fitness tracker that will be used to deliver their personalized exercise program, exercise monitoring, feedback, and motivational messages.
Group II: Health educationPlacebo Group1 Intervention
The health education group will receive the same amount of contact hours as the intervention group. The attention control group will receive health education and stretching exercises. Participants will be in person, on-site one time per week during month 1 for about 30 minutes. During month 2, participants will attend the health education on-site once every other week for about 30 minutes. During months 2-6 participants will receive a phone call every two weeks to help remind about the health education. Participants will receive a Fitbit fitness tracker that will be used for exercise monitoring.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

A systematic review of 27 studies involving 2565 participants with mild cognitive impairment (MCI) found that physical and mental exercises, such as Tai Chi and dance, significantly improved cognitive performance, as indicated by various cognitive assessment scores.
These exercises not only enhanced cognitive abilities but also positively affected biomarkers, increasing levels of the beneficial αβ1-42 protein and decreasing Tau protein levels, suggesting a potential mechanism for their efficacy in managing MCI.
Effects of mind-body exercise on cognitive performance in middle-aged and older adults with mild cognitive impairment: A meta-analysis study.Cai, H., Zhang, K., Wang, M., et al.[2023]
The PrAISED intervention, which involved up to 50 therapy sessions focusing on exercise and functional activities for adults with early dementia or mild cognitive impairment, did not show significant improvements in daily living activities, physical activity, or quality of life compared to usual care after 12 months.
Although the intervention group experienced fewer falls (79 falls) compared to the control group (200 falls), the difference was not statistically significant, indicating that the exercise program did not effectively reduce fall risk or improve overall health outcomes.
Promoting Activity, Independence, and Stability in Early Dementia and mild cognitive impairment (PrAISED): randomised controlled trial.Harwood, RH., Goldberg, SE., Brand, A., et al.[2023]
Exercise significantly improves global cognitive function in patients with mild cognitive impairment, with a strong effect size (SMD = 0.64) based on a meta-analysis of 21 studies.
In addition to cognitive benefits, exercise also enhances balance (SMD = 0.62) and reduces symptoms of depression (SMD = -0.37), indicating its potential as a comprehensive intervention for this population.
The effectiveness of exercise on global cognitive function, balance, depression symptoms, and sleep quality in patients with mild cognitive impairment: A systematic review and meta-analysis.Liu, X., Wang, G., Cao, Y.[2023]

References

Effects of mind-body exercise on cognitive performance in middle-aged and older adults with mild cognitive impairment: A meta-analysis study. [2023]
Promoting Activity, Independence, and Stability in Early Dementia and mild cognitive impairment (PrAISED): randomised controlled trial. [2023]
The effectiveness of exercise on global cognitive function, balance, depression symptoms, and sleep quality in patients with mild cognitive impairment: A systematic review and meta-analysis. [2023]
The Use of Home-Based Nonimmersive Virtual Reality to Encourage Physical and Cognitive Exercise in People With Mild Cognitive Impairment: A Feasibility Study. [2022]
SMARTfit Dual-Task Exercise Improves Cognition and Physical Function in Older Adults With Mild Cognitive Impairment: Results of a Community-Based Pilot Study. [2023]
Home-based exercise program for older adults with Motoric Cognitive Risk syndrome: feasibility study. [2021]
Balance on the Brain: a randomised controlled trial evaluating the effect of a multimodal exercise programme on physical performance, falls, quality of life and cognition for people with mild cognitive impairment-study protocol. [2022]
Effects of a specially designed aerobic dance routine on mild cognitive impairment. [2022]
NeuroExercise: The Effect of a 12-Month Exercise Intervention on Cognition in Mild Cognitive Impairment-A Multicenter Randomized Controlled Trial. [2021]
Comparative efficacy of various exercise interventions on depression in older adults with mild cognitive impairment: A systematic review and network meta-analysis. [2023]
Review articles (Meta-Analyses) effects of walking on cognitive function in individuals with mild cognitive impairment: a systematic review and meta-analysis. [2023]
Effectiveness of exercise and physical activity interventions to improve long-term patient-relevant cognitive and non-cognitive outcomes in people living with mild cognitive impairment: a protocol of a systematic review and meta-analysis. [2022]